READING INTERNATIONAL INC Stock Compensation Disclosure
2020 Stock Incentive Plan
On December 5, 2024, the Company’s stockholders, upon recommendation of the Company’s board of directors, approved the Second Amendment to the 2020 Stock Incentive Plan, increasing the number of Class A Common Stock reserved for issuance under the 2020 Plan by an additional 3,500,000 shares.
Under the 2020 Plan, the Company may grant stock options and other share-based payment awards of our Class A Common Stock to eligible employees, directors and consultants. At December 31, 2025, there were 870,833 shares of Class A Common Stock available for issuance under the 2020 Plan.
Stock options are granted at exercise prices equal to the grant-date market prices and typically expire on either the fifth or tenth anniversary of the grant date, although the Company’s Compensation and Stock Options Committee (the “Compensation Committee”) may set different vesting times. In contrast to a stock option where the grantee buys our Company’s share at an exercise price determined on the grant date, a restricted stock unit (“RSU”) entitles the grantee to receive one share for every RSU based on a vesting plan, typically between one year and four years from grant. As discussed further below, a performance component has been added to certain of the RSUs or options granted to management. At the time the options are exercised or RSUs vest and are settled, at the discretion of management, we may issue treasury shares or make a new issuance of shares to the option or RSU holder.
Stock Options
We estimated the grant-date fair value of our stock options using the Black-Scholes option-valuation model, which takes into account assumptions such as the dividend yield, the risk-free interest rate, the expected stock price volatility, and the expected life of the options. We expensed the estimated grant-date fair values of options over the vesting period on a straight-line basis. Based on our historical experience, the “deemed exercise” of expiring in-the-money options and the relative market price to strike price of the options, we have not estimated any forfeitures of vested or unvested options.
Stock options to purchase 308,823 shares of Class A Common Stock were issued to the non-employee members of the Board of Directors upon their re-election to the Board in December 2025 for their services for their 2026 term. No other stock options were granted in 2025 to directors. On June 11, 2025, we issued options to purchase 2,087,885 shares of Class A Common Stock to our senior executives. These options have a vesting and a term and were granted in lieu of cash bonuses which would otherwise have been paid under our Company's Incentive Compensation Program. No other stock options were granted during 2025 to employees.
The weighted average assumptions used in the option-valuation model for option grants for the years 2025, 2024 and 2023 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2025 |
| 2024 |
| 2023 | |||
Stock option exercise price |
| $ | 1.41 |
| $ | 1.49 |
| $ | 1.92 |
Risk-free interest rate |
|
| 3.88% |
|
| 4.26% |
|
| 4.12% |
Expected dividend yield |
|
| — |
|
| — |
|
| — |
Expected option life in years |
|
| 5.50 |
|
| 5.50 |
|
| 5.50 |
Expected volatility |
|
| 50.51% |
|
| 55.26% |
|
| 53.20% |
Weighted average fair value |
| $ | 0.57 |
| $ | 0.81 |
| $ | 1.01 |
We recorded stock-based compensation expense of $961,000, $783,000, and $50,000 for 2025, 2024, and 2023, respectively. At December 31, 2025, the total unrecognized estimated compensation cost related to non-vested stock options was $1.0 million which is expected to be recognized over a weighted average vesting period of 8.64 years. No cash was received from option exercises in 2025, 2024 or 2023.
The following is a summary of the status of RDI’s outstanding stock options for the three years ended December 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding Stock Options | |||||||||||||
|
| Number of |
| Weighted Average |
| Weighted Average |
| Aggregate | |||||||
|
| Class A |
| Class B |
| Class A |
| Class B |
| Class A&B |
| Class A&B | |||
Outstanding - January 1, 2023 |
| 327,498 |
| — |
| $ | 15.87 |
| $ | — |
| 1.24 |
| $ | — |
Granted |
| 207,657 |
| — |
|
| 1.92 |
|
| — |
|
|
|
|
|
Exercised |
| — |
| — |
|
| — |
|
| — |
|
|
|
| — |
Expired |
| (122,376) |
| — |
|
| — |
|
| — |
|
|
|
|
|
Outstanding - December 31, 2023 |
| 412,779 |
| — |
| $ | 14.19 |
| $ | — |
| 1.79 |
| $ | — |
Granted |
| 1,499,755 |
| — |
|
| 1.49 |
|
| — |
|
|
|
|
|
Exercised |
| — |
| — |
|
| — |
|
| — |
|
|
|
| — |
Expired |
| (205,122) |
| — |
|
| — |
|
| — |
|
|
|
|
|
Outstanding - December 31, 2024 |
| 1,707,412 |
| — |
| $ | 1.63 |
| $ | — |
| 9.44 |
| $ | — |
Granted |
| 2,396,708 |
| — |
|
| 1.41 |
|
| — |
|
|
|
|
|
Exercised |
| — |
| — |
|
| — |
|
| — |
|
|
|
| — |
Expired |
| — |
| — |
|
| — |
|
| — |
|
|
|
|
|
Outstanding - December 31, 2025 |
| 4,104,120 |
| — |
| $ | 1.49 |
| $ | — |
| 6.52 |
| $ | — |
The following is a summary of the status of RDI’s vested and unvested stock options as of December 31, 2025, 2024 and 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vested and Unvested Stock Options | |||||||||||||
|
| Number of |
| Weighted Average |
| Weighted Average |
| Aggregate | |||||||
|
| Class A |
| Class B |
| Class A |
|
| Class B |
| Class A&B |
| Class A&B | ||
Vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
| 1,915,069 |
| — |
| $ | 1.64 |
| $ | — |
| 8.39 |
| $ | — |
December 31, 2024 |
| 207,657 |
| — |
|
| 0.48 |
|
| — |
| 8.94 |
|
| — |
December 31, 2023 |
| 205,122 |
| — |
|
| 15.92 |
|
| — |
| 0.56 |
|
| — |
Unvested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
| 2,189,051 |
| — |
| $ | 1.43 |
| $ | — |
| 6.52 |
| $ | — |
December 31, 2024 |
| 1,499,755 |
| — |
|
| 1.62 |
|
| — |
| 9.44 |
|
| — |
December 31, 2023 |
| 207,657 |
| — |
|
| 4.54 |
|
| — |
| 1.79 |
|
| — |
Restricted Stock Units
Time vested RSU awards to management typically vest 25% on the anniversary of the grant date and the remainder over a period of four years. Beginning in 2020, a performance component has been added to certain management equity grants, which vest on the third anniversary of their grant date based on the achievement of certain performance metrics. From 2021 onwards, RSUs have two vesting structures, which include time vesting and performance vesting. The majority of RSUs vest 75% evenly over a period of four years, with the remaining 25% contingent upon the achievement of certain performance metrics, vesting in full on the third anniversary of the date of the grant. In the case of our Chief Executive Officer, RSUs vest 50% evenly over a period of four years with the remaining 50%, contingent upon the achievement of certain performance metrics, vesting in full on the third anniversary of the grant date. In 2024 and in the second quarter of 2025, our Compensation Committee, upon the recommendation of our Chief Executive Officer and Board Chair, determined that due to liquidity management concerns, our Company would not pay cash bonuses for which our executive officers and other senior management may have been potentially eligible, and to issue stock options in lieu of such bonuses. Also in 2024 and 2025, our Compensation Committee determined not to issue long term incentive stock options or RSUs.
During the years ended December 31, 2025 and December 31, 2024, we recognized compensation expense related to RSUs of $1.0 million and $1.6 million respectively. The total unrecognized compensation expense related to these unvested RSUs was $1.1 million as of December 31, 2025.
Below is a table that shows the restricted stock units that have been issued and vested during the years ending December 31, 2025 along with the dollar value of these awards. No RSUs have been issued since the end of 2023.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of RSUs |
|
| $ value of RSUs | |||||||||||||||
|
| Granted |
| Vested |
| Forfeited |
| Unvested |
| Granted |
| Vested |
|
| Forfeited |
| Unvested | |||
2016 |
| 68,153 |
| 67,372 |
| 781 |
| — |
| $ | 815,160 |
| $ | 805,759 |
| $ | 9,400 |
| $ | — |
2017 |
| 70,538 |
| 70,006 |
| 532 |
| — |
|
| 1,124,348 |
|
| 1,115,852 |
|
| 8,496 |
|
| — |
2018 |
| 97,600 |
| 94,426 |
| 3,174 |
| — |
|
| 1,581,512 |
|
| 1,529,648 |
|
| 51,864 |
|
| — |
2019 |
| 59,258 |
| 56,154 |
| 3,104 |
| — |
|
| 944,070 |
|
| 894,065 |
|
| 50,005 |
|
| — |
2020 |
| 401,966 |
| 373,708 |
| 28,258 |
| — |
|
| 2,281,899 |
|
| 2,111,059 |
|
| 170,840 |
|
| — |
2021 |
| 361,593 |
| 333,040 |
| 28,554 |
| — |
|
| 2,185,222 |
|
| 2,001,875 |
|
| 183,347 |
|
| — |
2022 |
| 502,582 |
| 384,242 |
| 43,905 |
| 74,435 |
|
| 1,998,505 |
|
| 1,505,028 |
|
| 183,084 |
|
| 310,394 |
2023 |
| 671,682 |
| 324,802 |
| 8,464 |
| 338,416 |
|
| 2,173,049 |
|
| 1,051,150 |
|
| 27,343 |
|
| 1,094,556 |
Total |
| 2,233,372 |
| 1,703,750 |
| 116,772 |
| 412,851 |
| $ | 13,103,765 |
| $ | 11,014,436 |
| $ | 684,379 |
| $ | 1,404,950 |
Stock Repurchase Plan
Our Stock Repurchase Program expired on March 10, 2024. It has not been renewed. No stock has been repurchased by our Company since March 10, 2020.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 31, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Mar 29, 2024 | |
| 2022 | Mar 31, 2023 | |
| 2021 | Mar 16, 2022 | |
| 2020 | Mar 31, 2021 | |
| 2019 | Mar 16, 2020 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.